We performed a longitudinal analysis of bone quality in Stem cell antigen 1 (Sca-1) null mice. A tight temporal, site-specific association between Sca-1 deficient bone mineral density deficiency and reduced mesenchymal progenitor frequency was observed. Defects in trabecular microarchitecture and mineralization were, at least partially, responsible for the age-related reduction in toughness of Sca-1 -/-bones.
INTRODUCTION
Adult bone mass is maintained by an exquisite balance between bone formation by osteoblasts and bone resorption by osteoclasts. Disruption of this delicate equilibrium can lead to osteoporosis (OP); a multi-factorial, age-related metabolic bone disease characterized by reduction in bone mass, bone tissue microarchitectural deterioration, and increased fracture risk.
Type II or age-related OP involves a comparable loss of both cortical and trabecular bone, leading to fractures of the proximal femur, vertebrae, and other sites with mixed cortical and trabecular bone. This bone loss results from an age-associated reduction in bone formation during each remodeling cycle, likely due to impaired osteoblast production and/or function. (1) A variety of risk factors have been associated with osteoporosis (2) (3) (4) (5) (6) (7) (8) , with emerging evidence suggesting a close association between bone aging, disease and stem/progenitor cell defects. (9) Numerous animal and human studies have examined the links between mesenchymal or osteo-progenitor cell properties, aging and osteopenia, however, many results to date have been contradictory and confusing. Interpreting the results of these studies is further complicated by variations in the cell source site, isolation procedures, culture conditions, assay conditions, metrics, and developmental time points being evaluated. The clearest trends are observed in murine osteoporosis/osteopenia models, including SAMP6 (10, 11) and aged C57BL/6 (12) mice, which exhibit low bone mass and/or bone material and mechanical defects accompanied by altered mesenchymal progenitor properties (i.e. reduced numbers, proliferative capacity, or osteogenic differentiation capacity). Our laboratory generated an additional model, the Stem cell antigen-1 (Sca-1) knockout mouse, that mirrors some characteristics associated with agedependant osteoporosis, exhibiting both decreased bone formation and resorption. (9, 13) An 18-kDa glycosyl phosphatidylinositol-anchored cell surface protein of the Ly6 gene family, Sca-1 (a.k.a., Ly6a) is expressed by a variety of mature and stem/progenitor cell populations, including stem cells/progenitors of the blood (14) , muscle (15, 16) , liver (17, 18) , prostate (19, 20) , and mammary epithelium. (21) Analysis of Sca-1 deficient (Sca-1 -/-) mice has not only clarified the functions of Sca-1 in T cell signaling (13) , but has revealed that it plays a role in the self-renewal of hematopoietic (22) and mesenchymal (9) stem/progenitor cells. Sca-1 -/-mice exhibited normal bone development, but displayed decreased bone mass and increased brittleness by 12 months; skeletal changes that appeared to be the result of reduced bone formation due to both decreased mesenchymal progenitor frequency and self-renewal defects. (9) Sca-1 -/-mice were also found to have fewer osteoclasts, due, at least in part, to the inability of Sca-1 -/-osteoblasts to support osteoclastogenesis. (9) Despite the emerging evidence linking stem cell defects and osteoporosis, little is known about the initiation of these defects and their translation into bone quality during the phase of bone mass accrual in either rodent models or clinical studies. Although BMD continues to be used as a prime diagnostic tool for osteoporosis in the clinic, more recent reports have called into question its usefulness as a surrogate for bone strength. (23, 24) In so doing, the field is beginning to call for a more holistic approach, especially in animal models where destructive mechanical testing is possible, to take into account the contributions of geometry, structure, microarchitecture and material in evaluating the mechanical properties and overall quality of bone. (25) In this study, we further characterize the initiation and progression of the age-related osteoporotic phenotype of Sca-1 -/-mice at the cellular, structural, material and mechanical level at 3, 5, 7, and 9 months of age. We hypothesized that Sca-1 deficiency would lead to defects in mesenchymal progenitors and that these defects would be further reflected in inferior bone quality in Sca-1 -/-mice. We predicted that this deterioration in bone quality would translate into reduced mechanical toughness of bones from Sca-1 -/-mice.
MATERIALS AND METHODS

Animals
All mice were maintained in a specific pathogen free facility at Mount Sinai Hospital, Toronto, Canada. Female Sca-1 -/-and Sca-1 +/+ animals backcrossed for 10 generations on the BALB/c background (6) were analyzed at 3, 5, 7, and 9 months of age. In some cases, BALB/c controls purchased from Charles River Canada were used in place of backcrossed 
Bone Marrow Isolation
A minimum of 7 mice of each genotype, spread out over two separate experimental cohorts, were sacrificed by CO 2 asphyxiation at each time point. For each experimental cohort, femurs, tibias and pelvic bones were isolated from animals of each genotype and cleaned of any associated muscles or connective tissues with sterile gauze. Bone marrow was flushed from one femur (the other was reserved for biomechanical testing), both tibias and both pelvic bones using a 23-gauge needle and basal culture medium (-MEM (GIBCO) supplemented with 15% FBS (a pre-screened lot, GEMINI), 50U/mL penicillin (SIGMA), and 50µg/mL streptomycin (SIGMA)). Total bone marrow from each genotype was pooled and passed though a 40µm nylon mesh filter to remove any bone particulate. Recovered nucleated cells were enumerated and used for osteoclast and mesenchymal progenitor assays.
Bone Marrow Derived Osteoclast Cultures
Freshly isolated and enumerated bone marrow derived cells were plated at a density of 10 5 cells/ml in a 75cm 2 flask (FALCON) for 24 hours in basal osteoclast medium (-MEM (GIBCO) medium supplemented with 10% FBS (CANSERA), 50U/mL penicillin (SIGMA), and 50µg/mL streptomycin (SIGMA)) with 50ng/ml M-CSF and RANK-L (R & D). At the end of this period, the non-adherent fraction was isolated and plated in triplicate at a density of 5x10 5 
Mesenchymal Progenitor Assays
The frequency of mesenchymal progenitor cells in the bone marrow was evaluated using the colony-forming unit fibroblast (CFU-F) assay, while the osteogenic and adipogenic differentiation potentials of these mesenchymal progenitors were assayed using the colonyforming unit alkaline phosphatase (CFU-ALP), colony-forming unit osteoblast (CFU-O) and 
Histomorphometric Analysis
The 6 th lumbar vertebrae were isolated from each spine and embedded in spurr resin as described previously. (27) 5m thick sections were cut from each embedded sample using a semi-automatic microtome (Reichert-Jung 2050), stained with Goldner's Trichrome, (28) and quantified blindly using the Bioquant Nova Prime version 6.50.10 (Bioquant Corp.) image analysis system.
Back Scattered Electron Imaging:
The same Spurr blocks which contain the embedded 6 th Lumbar vertebrae were imaged using Back Scattered Electron (BSE) microscopy following standard protocol (29) and used for evaluation of mineralization distribution. Histograms of the gray level distribution were created, with increasing gray levels representing a higher degree of mineralization. (30, 31) From these histograms the peak mineralization value and the width at half maximal height (WHMH) were determined. Shifts in the mineralization profiles were compared via a logit function, which used cutoff gray level values of 95, 115, 117 and 110 for the 3, 5, 7 and 9 month time points, respectively (32) :
where "proportion" indicates histogram area.
DEXA Analysis
Dual Energy X-ray Absorptiometry was performed using a small animal PIXImus densitometer (Lunar, GE Corp.) for the whole animal under anesthesia at each time point. Following sacrifice, femurs and lumbar spines (L1 -L5) were scanned for determination of BMD, BMC and Area.
For analysis, a region of interest with consistent dimensions was chosen for uniformity between the two genotypes of mice.
Microcomputed Tomography:
The fourth lumbar vertebra (L4) of each mouse was isolated and scanned using micro computed tomography (CT) to evaluate both cortical and trabecular bone parameters. Groups of four vertebrae were embedded in microtubes using epoxy resin to eliminate movement during the scan. Each group was scanned using a desktop CT with a 6.5 m voxel size for 3 hours (GE 
Mechanical Testing:
Three point bending and vertebral compression tests were performed as described previously. (9) Proximal ends of femurs tested for three point bending tests were used for the femoral neck fracture test which was performed at a cross-head speed of 1mm/min using standard procedure. (33) 
Statistical Analysis
For all analyses, with the exception of parameters measured through whole body DEXA scans, Two-way Analysis of Variance tests (Two-way ANOVA), with Student Neuman-Keul's posthoc tests were used. Since whole body DEXA scans were discontinued for some mice following dissection at 3, 5 or 7 month time points, while for others they continued until 9 months of age, unpaired Student's T tests with a two-tail distribution were used to compare the differences in DEXA parameters between the two genotypes at each time point. A calculated p-value≤ 0.05 was accepted as significant.
RESULTS
In Vitro Osteoclastogenesis with Age
To test for cell-intrinsic osteoclast defects, both splenocytes and bone marrow derived cells were grown in osteoclastogenic conditions. In the splenocyte-derived cultures both genotypes exhibited peak numbers of mononucleated and multinucleated TRAP + osteoclasts at 7 months of age ( Figure 1A ). No differences were observed between the two genotypes in either the mononucleated or the multinucleated TRAP + cells at 3 months of age. Surprisingly, at 5 months and 7 months, the Sca-1 -/-mice showed a reduced ability to form mononucleated TRAP + osteoclast cells. In addition, reduced numbers of Sca-1 -/-multinucleated TRAP + cells were observed at both 5, 7 and 9 months of age. This defect increased from a 60.5% reduction at 7 months to a 79.8% decrease by 9 months of age.
Similar trends were observed in osteoclast cultures derived from the bone marrow, with TRAP + cell numbers peaking for both genotypes at 7 months of age ( Figure 1B) . A comparison between the two genotypes revealed greater mononucleated TRAP + cells in Sca-1 -/-cultures at 3 months, no differences at 5 and 7 months, and decreased Sca-1 -/-cells at 9 months of age. For multinucleated cells, no differences were observed between the two genotypes at 3 and 5 months.
However, from 7 months onwards, cells from the Sca-1 -/-mice showed a reduced ability (26%) to form multinucleated osteoclasts, a defect more pronounced (32%) at 9 months. These results suggest that in addition to our previous finding of a cell non-autonomous defect in osteoclastogenesis due to reduced osteoblasts (9) , Sca-1 -/-mice develop a cell autonomous osteoclast defect during aging.
In Vitro Mesenchymal Progenitor Frequency with Age
To determine when the previously observed (9) defect in Sca-1 -/-mesenchymal progenitors first arises and whether it increased in magnitude with age, the average number (and frequency) of 
In vivo Bone Formation with Age
To determine if Sca-1 -/-vertebrae exhibit an age-dependent reduction in osteoid secretion, static histomorphometry was performed. Although no differences between genotypes were observed at 3 months of age, from 5 months onwards Sca-1 -/-vertebrae displayed both reduced osteoid volume and surface, with maximal reductions of 70% and 52%, respectively, observed at 7 months ( Figure 3A and 3B). No differences, however, were detected in osteoid thickness at any of the time points analyzed ( Figure 3C ).
Mineralization Profiles with Age
To determine the effect of reduced bone formation on the degree of mineralization within the trabecular compartment of vertebrae, backscattered electron imaging was performed. No significant differences were observed between the two genotypes at the 3-and 5-month time points for any of the mineralization parameters assessed. However at seven months, a trend (0.05<p<0.1) towards a greater peak value of mineralization, accompanied by reduced width at half maximal height (WHMH) was observed in Sca-1 -/-vertebrae. However, no significant differences were observed in the logit value between the two genotypes at the seven month time point. Consistent with these trends, 9-month old Sca-1 -/-vertebrae also exhibited greater values of peak mineralization and decreased WHMH and logit values (Table 1) .
DEXA Analysis with Age
Although our previous work (9) revealed that Sca-1 -/-mice exhibited decreased whole body BMD compared to controls by 12 months of age, it remained unclear whether this reduction was due to a failure to accrue bone mass with age or loss of bone mass with age. Therefore, in this study, longitudinal DEXA analysis was performed, which revealed that the whole body BMD of both Figure 4C ).
Trabecular Bone Mass and Microarchitecture with Age
Since no significant differences were observed in spinal BMD between the two genotypes despite reduced Sca-1 null bone formation, a more sensitive analysis via -CT was undertaken, enabling separate measurement of the cortical and trabecular regions of bone. Reduced trabecular volumetric BMD (tvBMD) was observed in Sca-1 -/-mice at 7 and 9 months of age, compared to controls, with decreases of 20.1% and 16.4%, respectively (Table 3) . No statistically significant differences, however, were seen in cortical BMD or BMC at any age (Table 1) . This reduced trabecular bone mass in Sca-1 -/-mice was accompanied by a reduced bone volume fraction (BVF) and inferior stereology, with a trends towards reduced trabecular number and increased trabecular spacing observed at 7 months (Table 3, Figure 5 ).
Vertebral Mechanical Properties with Age
To determine if the reduced material and microarchitectural properties and a greater degree of mineralization of the trabecular compartment in 
Three Point Bending Test
To determine the effect of Sca-1 on the mechanical properties of cortical bone, the three point bending test was performed in which femurs were fractured at the mid diaphysis; a region Deformation. As observed in the Femoral Neck Fracture Test, no differences were observed in the Ultimate Load between the two genotypes at any of the time points examined. In addition, no differences were observed in either the anterior-posterior diameter or the moment of inertia between the two genotypes at any time point (Table 8 ). Similar trends were observed when the parameters were normalized, with significantly reduced Toughness observed for Sca-1 -/-femurs at 5 and 7 months of age.
DISCUSSION
Initial analysis of the bone phenotype in Sca-1 -/-mice by our lab (9) revealed an age-related decrease in bone material and mechanical properties, with concomitant defects in mesenchymal progenitor self-renewal and decreased osteoclastogenesis. However, all analyses were limited to two time points or less; thus many questions remained regarding the initiation and progression of the Sca-1 null skeletal phenotype. Here, we have longitudinally characterized Sca-1 -/-bone properties on a cellular, structural, material and mechanical level using the same animals.
In our previous studies of the Sca-1 null hematopoietic phenotype, although no defects in spleen, or bone marrow cellularity were observed, Sca-1 deficient mice displayed megakaryocytic lineage differences, including mild thrombocytopenia (which did not affecting bleeding times), as well as fewer platelets, megakaryocytes, and megakaryocyte precursors (CFU-Mk, and CFU-GEMM). (22) Interestingly, while clonogenic assays revealed a slight increase in Sca-1 null bone marrow-derived monocyte precursors (CFU-M), there were no differences in bone marrow monocyte number or frequency. (22) This minor hematopoietic lineage skewing, however, does not appear to account for the in vivo reduction in Sca-1 null TRAP + osteoclasts that we observed previously at 2 and 9 months of age. demonstrating increased sensitivity to osteoclastogenic inhibition, (34, 35) and bone marrow-derived precursors exhibiting increased osteoclastogenesis in vitro; (36) a trend reflected in our observations at 7 and 9 months where defects in formation of multinucleated osteoclasts were more severe in splenocyte compared to bone marrow populations, despite a dramatic reduction in
Previously, we observed Sca-1 -/-mesenchymal progenitor defects as early as 2 months of age in clonogenic assays utilizing expanded passage 1 (P1) cultures. (9) However, since these defects included reduced self-renewal of primitive progenitors resulting in reduced clonogenic cells (CFU), the current studies were all performed using primary (P0) cells to more accurately reflect the in vivo activity of mesenchymal progenitors and thus assess the onset and progression of the Sca-1 -/-mesenchymal cellular phenotype. Several protocol changes between our previous and current clonogenic assays were thus necessary to adapt to using P0 cells, most notably different serum lots, cell densities, and culture vessel sizes. Under these conditions that supported growth and differentiation of cells from both wild type and Sca-1 null mice, dramatic in vitro reductions in CFU-F, CFU-ALP, and CFU-O were first observed in Sca-1 null mice at 7 months, the same time point when reduced Sca-1 -/-femoral BMD begins, suggesting a sitespecific relationship between BMD and total osteoprogenitors. However, less striking increases in Sca-1 -/-osteoprogenitors at earlier time points were not associated with increased bone mass, implying that this relationship may be threshold-dependent. Wild type mice, meanwhile, exhibited a steady increase in the total number of mesenchymal progenitors (CFU-F) and concomitant committed progenitors (CFU-ALP, CFU-O, and CFU-A) during accrual of BMD.
This finding during our longitudinal analysis of the buildup to peak bone mass provides further evidence of the important role of primitive mesenchymal progenitors in bone growth and homeostasis.
Results of the Sca-1 null osteogenic and adipogenic differentiation assays generally mirrored CFU-F assay trends (i.e. increased progenitors at earlier time points followed by dramatic decreases later on) strongly suggesting that defects in primitive mesenchymal progenitors or stem cells serve as the driving force behind the Sca-1 null cellular phenotype.
Additional osteogenic and adipogenic differentiation defects, however, cannot be discounted, since the percentage differences between wild type and mutant CFU-ALP and CFU-O exceeded those observed in CFU-F. Interestingly, Sca-1 -/-mice exhibit age-related bone loss accompanied by decreased in vitro adipogenesis, unlike in SAMP6 and aged C57Bl/6 age-related murine osteoporosis models, where increased marrow adipogenesis is observed. We propose that the pool of Sca-1 -/-mesenchymal and osteo-progenitors fail to expand with age, as in wild type animals, thus leading to the reduced bone formation observed histologically. Furthermore, this expansion defect is consistent with stem/progenitor cell exhaustion, due to increased differentiation at the expense of homeostatic self-renewal. This is supported by our current observation that Sca-1 -/-osteoprogenitors peak early, and our previous study revealing a selfrenewal defect in Sca-1 -/-mesenchymal stem/precursor cells. (9) In addition to the osteoclast and mesenchymal progenitor defects characterized in this study, Sca-1 -/-mice also exhibit hematopoietic, (13, 22, 37) and myogenic defects (38) of a nature that implies that Sca-1 plays a role in the control of stem cell/primitive progenitor cell maintenance and thus homeostasis of multiple tissues.
In our earlier investigation we demonstrated reduced bone formation in Sca-1 -/-femurs and vertebrae using both static and dynamic histomorphometry, respectively. Whole body BMD increased with age for both strains, suggesting that Sca-1 null mice do indeed accrue bone mass, albeit at a lower level than wild type controls. Several studies indicate that BMD is differentially regulated at different anatomical sites in the skeleton, as well as within different compartments of the same bone. (39) (40) (41) Our observations that reductions in Sca-1 -/-whole body BMD preceded those in femoral BMD add further evidence to these findings and underscore the importance of choosing multiple skeletal sites in evaluating bone mass. Our observation at 3 months that greater whole body BMD was associated with increased muscle mass and weight in control mice may indicate that the influence of Sca-1 on bone mass at this early time point was indirect and mediated through greater mechanical loading in the more muscular, heavier controls. However, recent studies (33) While DEXA analysis revealed reduced whole body and femoral BMD in Sca-1 -/-mice, no significant differences were observed in spinal BMD between the two genotypes, despite reduced bone formation. Therefore, for the first time, to our knowledge, in a longitudinal study in BALB/c mice, we separately analyzed the trabecular compartment and the cortical shell of the vertebral body using -CT. At this higher resolution we observed significantly inferior material and microarchitectural properties in the trabecular compartment of Sca-1 null vertebrae at 7 months; the same time point at which in vitro mesenchymal and osteoprogenitor defects were first witnessed, thus suggesting a correlation between the cellular phenotype and trabecular microarchitecture. These findings highlight one of the bases of the inferior vertebral mechanical properties observed in Sca-1 deficient mice, while on a larger scale they reinforce the growing concern regarding the use of BMD as a surrogate measurement for bone strength and as the gold standard for diagnosing osteoporosis. (24, 33) We tested the mechanical properties of bone at two sites particularly susceptible to developing osteoporotic fractures, the lumbar spine and femoral neck. Compression tests performed on the 5 th lumbar spine indicated that Sca-1 mutant vertebrae exhibited both reduced strength and ductility and thus required decreased energy to fracture as compared to wild type controls. These inferior structural properties were primarily due to the inferior intrinsic mechanical properties of Sca-1 -/-vertebrae, rather than geometric differences between the two genotypes, as indicated by similar reductions in normalized energy to failure (Toughness).
Femoral neck fracture tests again demonstrated that Sca-1 -/-bones were less ductile than controls and therefore required less energy to fracture, although in this case no differences were observed in bone strength. Three point bending test revealed reduced ductility for Sca-1 null femurs at 5 months of age. Although it is difficult to predict the exact mechanistic basis for this reduced ductility we know that it is not due to geometric differences between the two genotypes. Unlike femoral neck fracture and compression tests, a further exacerbation of the mechanical defect was not observed in three point bending. This may be due to the fact that the mid-diaphysis region, unlike the proximal femoral head and lumbar spine, is predominantly composed of cortical bone and is therefore less likely to be influenced by stem cell defects within the bone marrow than trabecular sites. Interestingly, the extent of the initial Sca-1 null mechanical defect lessened with age, which could be the result of a mechanical adaptation of cortical bone in response to severe deterioration of the trabecular microarchitecture following the initiation of cellular defects.
Interestingly, inferior mechanical properties in Sca-1 -/-bones were first observed at 5 months of age, prior to the observed onset of mesenchymal progenitor defects. This could be due to a number of possibilities. Firstly, the cellular assays were performed in vitro using conditions tailored to support the growth of both Sca-1 null and wild type primary (P0) mesenchymal progenitors. Thus, we cannot rule out the possibility that more subtle cellular defects, which initiate the deterioration of bone quality in vivo, may not have been revealed in this in vitro environment. Secondly, bone mechanical properties are determined by the complex interplay of a variety of factors including bone mineral density, material, microarchitecture, and anisotropy ratio; (42) Sca-1 expression in mesenchymal cells may affect many of these parameters. Therefore, it is possible that Sca-1 plays multiple roles in bone homeostasis, including the expansion and self-renewal of the mesenchymal progenitor pool required for lifelong bone formation, as well as regulation of other determinants of bone quality. This is the first study, to our knowledge, to longitudinally examine either osteoclast or mesenchymal progenitor cell populations in BALB/c wild type mice during the accrual of peak bone mass. Our results, in contrast with those from other murine studies which examined limited time points, (43, 44) suggest that the association between aging and increased bone marrow derived osteoclast precursors is not necessarily linear. Various rodent studies have linked bone loss to reduced numbers of mesenchymal and/or osteo-progenitors and/or alterations in osteogenic differentiation capability. (12, 45, 46) When specifically examining the effects of age, (12, 47, 48) including in BALB/c mice, (49) 'old' 22-24 month-old mice generally exhibit reduced numbers of CFU-F and/or osteoprogenitors compared to 'young' 4-5 month-old mice. However, the few studies comparing younger groups of mice have observed no differences in CFU-F number (2 vs. Aside from Sca-1 null mice, several murine models have been proposed for agedependent osteoporosis, including the well-characterized SAMP6 and C57Bl/6 strains. SAMP6 mice exhibit inferior cortical mechanical properties by 4 months of age via femoral four point bending analysis, despite no differences in femoral BMD. (55) Sca-1 null mice also exhibited mechanical defects in both the femur and vertebrae, however, unlike in C57Bl/6 mice, the onset of both these cortical and trabecular deficiencies manifested earlier and at the same age. Type II osteoporosis is associated with a comparable deterioration of bone quality at sites containing both trabecular and cortical bone, Sca-1 null mice thus provide a closer approximation of the human disease phenotype than SAMP6 and C57Bl/6 mice.
To our knowledge, this is the most comprehensive study longitudinally examining bone cellular, material, microarchitectural and mechanical properties using the same cohorts of mice.
We have demonstrated a tight connection within Sca-1 null mice between the initiation of stem 
